Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Tumori. 2022 Feb;108(1):6-11. doi: 10.1177/03008916211047268. Epub 2021 Sep 29.
The advent of technologies allowing the global analysis of biological phenomena, referred to as "omics" (genomics, epigenomics, proteomics, metabolomics, microbiomics, radiomics, and radiogenomics), has revolutionized the study of human diseases and traced the path for quantitative personalized medicine. The newly inaugurated Master of Science Program in Biomedical Omics of the University of Milan, Italy, aims at addressing the unmet need to create professionals with a broad understanding of omics disciplines. The course is structured over 2 years and admits students with a bachelor's degree in biotechnology, biology, chemistry, or pharmaceutical sciences. All teaching activities are fully held in English. A total of nine students enrolled in the first academic year and attended the courses of radiomics, genomics and epigenomics, proteomics, and high-throughput screenings, and their feedback was evaluated by means of an online questionnaire. Faculty with different backgrounds were recruited according to the subject. Due to restrictions imposed by the coronavirus disease 2019 (COVID-19) pandemic, laboratory activities were temporarily suspended, while lectures, journal clubs, and examinations were mainly held online. After the end of the first semester, despite the difficulties brought on by the COVID-19 pandemic, the course overall met the expectations of the students, specifically regarding teaching effectiveness, interpersonal interactions with the lecturers, and courses organization. Future efforts will be undertaken to better calibrate the overall workload of the course and to implement the most relevant suggestions from the students together with omics science evolution in order to guarantee state-of-the-art omics teaching and to prepare future omics specialists.
允许对生物现象进行全球分析的技术的出现，被称为“组学”（基因组学、表观基因组学、蛋白质组学、代谢组学、微生物组学、放射组学和放射基因组学），它彻底改变了人类疾病的研究，并为定量个性化医学开辟了道路。意大利米兰大学新开设的生物医学组学理学硕士课程旨在满足创建对组学学科有广泛了解的专业人员的未满足需求。该课程为期 2 年，招收生物技术、生物学、化学或制药科学学士学位的学生。所有教学活动均以英语进行。共有 9 名学生在第一学年注册，并参加了放射组学、基因组学和表观基因组学、蛋白质组学和高通量筛选课程，他们的反馈通过在线问卷进行了评估。根据学科背景，招募了具有不同背景的教师。由于 2019 年冠状病毒病（COVID-19）大流行的限制，实验室活动暂时暂停，而讲座、期刊俱乐部和考试主要在线进行。第一学期结束后，尽管受到 COVID-19 大流行的影响，该课程总体上满足了学生的期望，特别是在教学效果、与讲师的人际交往和课程组织方面。未来将努力更好地调整课程的整体工作量，并结合组学科学的发展实施学生的最相关建议，以保证最先进的组学教学，并为未来的组学专家做好准备。
